← Back
$ACAD All transactions

ACADIA PHARMACEUTICALS INC

▼ SELL

$ Value

$315K

Shares

14,446

Price

$22

Filed

Jun 5

Insider

Name

Brege Laura

Title

CIK

0001365619

Roles

Director

Transaction Details

Transaction Date

2025-06-04

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

15,095

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $21.77 through $21.81, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein.

Filing Info

Accession No.

0001415889-25-015832

Form Type

4

Issuer CIK

0001070494

Brege Laura's History

Date Ticker Type Value
2025-09-11 MIRM M $255K
2025-09-11 MIRM $1.2M
2025-09-11 MIRM $112K
2025-09-11 MIRM M $0
2025-06-16 EWTX A $0
2025-06-11 PCRX A $0
2025-06-11 PCRX A $0
2025-06-04 ACAD $315K
2025-05-29 ACAD M
2025-05-29 ACAD M $0

Other Insiders at ACAD (90d)

Insider Bought Sold Last
Rhodes Jennifer J
EVP, CHIEF LEGAL OFFICER, SEC
$83K 2026-03-25
Kihara James
PRINCIPAL ACCOUNTING OFFICER
$65K 2026-04-07
Owen Adams Catherine
Chief Executive Officer
$250K 2026-03-25
Thompson Elizabeth H.Z.
EVP, Head of Research & Dev
$74K 2026-03-25
Schneyer Mark C.
EVP, CHIEF FINANCIAL OFFICER
$219K 2026-04-07